NASDAQConsumer DiscretionarySpecialty RetailSnapshot 2026-11-04
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
Matching fiscal periods, usable estimates and at least one analyst are required.
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
The calculation requires same-period, same-provider snapshots, positive EPS, at least one analyst and a baseline within three days of the requested lookback.
The EPS and P/E reference is not available for TLF yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
Three published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Return to operating profitability | A primary condition in Tandy Leather Factory Inc's published investment case. The stated target is Operating income >= $365,000 in 2026-Q1. | Intact | Operating income falls below $0 in 2026-Q1 | Operating income: $543,000 FY2026-Q2; GAAP. Published target: Operating income >= $365,000 in 2026-Q1. The stored target says 2026-Q1; this source reports FY2026-Q2. Fiscal/calendar alignment needs review. Aug 11, 2026543,000 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
Comparable estimate history is unavailable.
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Compare required revenue and earningsMonthly analyst history is unavailable.
Recent actions · Oct 6–Nov 4 · 0 recorded
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Nov 9, 2026
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
This is a small-cap recovery story, not yet a proven durable compounder, because earnings quality is fragile and the business is loss-making in the broader assessment. The long-term thesis is on watch: operating results have improved, but recent company momentum and the overall signal have weakened.
TLF trades at a premium to peers, while the valuation assessment says expectations and fundamentals are aligned and the priced-in fragility is low. The expectations gap is negative, so the market setup does not appear to leave much room for execution to fall short; confidence in this reading is medium.
Near term, management has made progress toward operating profitability, with operating income moving from a loss in 2025-Q4 to a profit in 2026-Q2; revenue and gross margin have also improved in the cited periods. However, a February earnings miss, weaker recent momentum, and performance below the industry cohort point to continued execution risk, including the possibility of a guidance cut.
Over the next few quarters, the key test is whether TLF sustains operating profitability and follows through on sales growth and margin improvements. A guidance cut or weaker results from consumer discretionary bellwethers such as AMZN, BABA, and PDD would weaken the setup; continued strength from those companies could support the sector backdrop.
Over a 1-to-3-year view, TLF shows early operational progress, but fragile earnings quality, elevated risk, and a premium to peers leave the thesis dependent on sustained execution. The evidence supports a watchful, mixed assessment rather than a settled recovery story. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Stated as a priority in 2 of last 2 quarters. Operating income improved from a loss of $613,000 in 2025-Q4 to a positive $543,000 in 2026-Q2. Management's focus on returning to operating profitability in 2026 is reflected in this improving trajectory, indicating progress toward this goal.
Delivery assessment Sep 8, 2026Sustain sales growth to support profitability | The company is focusing on sales growth to support profits. | Intact | Revenue growth falls below 1% YoY next year | Revenue growth: 1.52% FY2026-Q2; GAAP. Published target: Revenue growth >= 1% YoY in next 4 quarters. Target period is not explicitly aligned with this observation. Aug 11, 20261.524785 percent · calculatedLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated as a priority in 2 of last 2 quarters. Revenue increased from $17.35 million in 2024-Q3 to $19.65 million in 2026-Q1, showing growth in sales. Management's recurring focus on sales growth aligns with this positive revenue trend, indicating delivery on this priority. Delivery assessment Sep 8, 2026 |
Maintain valuation discount to peers | The valuation is cheap compared to peers. | Intact | Price rises above peer median PE without profit gains | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
3 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.